India to United States: Exemestane Export Trade Route
India has recorded 66 verified shipments of Exemestane exported to United States, representing a combined trade value of $4.6M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $70.3K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 48% of total export value with 27 shipments worth $2.2M USD. On the buying side, AUROBINDO PHARMA USA., INC, is the largest importer in United States with $709.8K USD in purchases. The top 3 suppliers — EUGIA PHARMA SPECIALITIES LIMITED, MSN LABORATORIES PRIVATE LIMITED, ZYDUS LIFESCIENCES LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Exemestane corridor is one of India's established pharmaceutical export routes, with 66 shipments documented worth a combined $4.6M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 48% of all export value, reflecting the consolidated nature of India's exemestane manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $70.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (60%) and air (40%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July-September, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 11.1%, placing it at rank #2 among India's top exemestane export destinations globally.
On the import side, key buyers of Indian exemestane in United States include AUROBINDO PHARMA USA., INC,, XXDUSXXHARXXCEUXXCALXXUSAXXNC, AUROBINDO PHARMA USA INC and 12 others. AUROBINDO PHARMA USA., INC, is the single largest importer with 9 shipments valued at $709.8K USD.
